Allopurinol in Acute Gout

Allopurinol in Acute Gout The Title Will Not be Change as the Study as Been Closed.

Status

Withdrawn

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01775098

Enrollment

Registered

2013-01-24

Start date

Unknown

Completion date

2013-02-28

Last updated

2017-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gout

Keywords

Gout, uric acid, allopurinol

Brief summary

The objectives of the present study are to determine if starting treatement of hyperuricemia with allopurinol during an acute gout crises has an impact on the duration or the severity of the crises

Interventions

DRUGallopurinol

No arms will not be change as the study as been closed.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

More than 18 years old Able to sign informed consent Indication of long-term treatment with allopurinol Acute gout crisis

Exclusion criteria

Les than 18 years-old Unable to consent Contra-indication to allopurinol

Design outcomes

Primary

Measure	Time frame	Description
Duration of the gout crises	First 7 days after visit	Presence of inflammatory signs

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026